{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:11Z","timestamp":1783595171879,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":1846,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/ajt.14386","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T11:42:39Z","timestamp":1499514159000},"page":"2863-2868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change"],"prefix":"10.1016","volume":"17","author":[{"given":"C.E.","family":"Kling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Landis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sibulesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14386_bib1","unstructured":"UNOS [Internet]. Unos.org. 2017 [cited 16 March 2017]. Available from: https:\/\/www.unos.org"},{"key":"10.1111\/ajt.14386_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2014.09.023","article-title":"Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: An open-label study","volume":"148","author":"Curry","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.14386_bib3","doi-asserted-by":"crossref","first-page":"e12660","DOI":"10.1111\/tid.12660","article-title":"Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens","volume":"19","author":"Shah","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/ajt.14386_bib4","doi-asserted-by":"crossref","first-page":"e12659","DOI":"10.1111\/tid.12659","article-title":"Successful treatment of donor-derived hepatitis C infection in a lung transplant recipient","volume":"19","author":"Theodoropoulos","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/ajt.14386_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C-infected donor livers in the recent era","volume":"17","author":"Bowring","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14386_bib6","unstructured":"UNet System Notice - Upcoming Waitlist and DonorNet changes will reflect policy changes regarding infectious diseases screening [Internet]. UNOS System Notices - General Notice. 2017 [cited 16 March 2017]. Available from: https:\/\/portal.unos.org\/ViewSystemNotice.aspx?id=3074"},{"key":"10.1111\/ajt.14386_bib7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-6143.2009.02992.x","article-title":"Nucleic acid testing (NAT) of organ donors: Is the \u2018best\u2019 test the right test? A consensus conference report","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14386_bib8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1600-6143.2011.03518.x","article-title":"Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States","volume":"11","author":"Ellingson","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14386_bib9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e318219eb8f","article-title":"Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: A European multicentric case-control study","volume":"91","author":"Ballarin","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14386_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.14386_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.510290311","article-title":"Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection","volume":"29","author":"Villano","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/ajt.14386_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepatitis"},{"key":"10.1111\/ajt.14386_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cid\/ciw676","article-title":"Late relapse versus hepatitis C virus reinfection in patients with sustained virologic response after sofosbuvir-based therapies","volume":"64","author":"Sarrazin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.14386_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: A systematic review and meta-analysis","volume":"62","author":"Simmons","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.14386_bib15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2008.05.044","article-title":"Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"135","author":"Maylin","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.14386_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e3181ac620b","article-title":"A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk index","volume":"88","author":"Rao","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14386_bib17","unstructured":"KDPI Calculator - OPTN [Internet]. OPTN. 2017 [cited 16 March 2017]. Available from: https:\/\/optn.transplant.hrsa.gov\/resources\/allocation-calculators\/kdpi-calculator\/"},{"key":"10.1111\/ajt.14386_bib18","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14386","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522252046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522252046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14386\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:18:56Z","timestamp":1761628736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522252046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1600613522252046"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14386","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}